Citations 1
Durable Response to Everolimus in Metastatic Hepatic Epithelioid Cell Tumor With TSC2 and NF2 Mutations
Thitvirachawat, Sasipim, Patrathiranond, Piraya, Eiamprapaporn, Panuch, Eiamprapaporn, Panuch
Asian Medical Journal and Alternative Medicine | April 10, 2026 | Volume: 26 | Issue: 1 | Pages: 52-55
We report a case of a 63-year-old male with metastatic hepatic PEComa harboring TSC2 and NF2 mutations who achieved a durable partial response to everolimus with only mild adverse effects. This case highlights the value of genomic profiling and the efficacy of mTOR inhibitors in hepatic PEComa management.